<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01423227</url>
  </required_header>
  <id_info>
    <org_study_id>HomeBase</org_study_id>
    <nct_id>NCT01423227</nct_id>
  </id_info>
  <brief_title>Benefits and Costs of Home-based Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease</brief_title>
  <acronym>HomeBase</acronym>
  <official_title>Benefits and Costs of Home-based Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>La Trobe University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Alfred</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Austin Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Monash University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>La Trobe University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pulmonary rehabilitation is an effective treatment for people with chronic obstructive&#xD;
      pulmonary disease (COPD) which improves symptoms, reduces hospitalisation and lowers&#xD;
      healthcare costs. However less than 1% of Australians with COPD receive pulmonary&#xD;
      rehabilitation each year, due to poor access to programs and high levels of disability. This&#xD;
      randomised controlled trial will examine the benefits and costs of a novel, entirely&#xD;
      home-based pulmonary rehabilitation program for COPD. We hypothesise that home-based&#xD;
      pulmonary rehabilitation can deliver equivalent clinical outcomes at lower cost than the&#xD;
      centre-based program.&#xD;
&#xD;
      We will randomly allocate 144 people with COPD to undertake either standard pulmonary&#xD;
      rehabilitation in a hospital setting, or a low-cost home-based program. Those who undertake&#xD;
      pulmonary rehabilitation in the hospital setting will attend the hospital twice each week for&#xD;
      eight weeks for supervised exercise training and education. People in the home pulmonary&#xD;
      rehabilitation group will receive one home visit and weekly telephone calls for eight weeks,&#xD;
      for supervision and mentoring of exercise and provision of education. We will compare the&#xD;
      number of people who complete the program in each setting. We will also test whether the&#xD;
      groups have similar results for the standard pulmonary rehabilitation outcomes of&#xD;
      breathlessness, quality of life and exercise capacity, at the end of the program and 12&#xD;
      months later. We will compare health care costs and personal costs between groups after 12&#xD;
      months.&#xD;
&#xD;
      If home-based pulmonary rehabilitation can improve uptake of this important treatment,&#xD;
      deliver good clinical outcomes and reduce costs this will have significant and long-lasting&#xD;
      benefits for patients, the community and the health system&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2011</start_date>
  <completion_date type="Actual">May 2015</completion_date>
  <primary_completion_date type="Actual">May 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in 6-minute walk test</measure>
    <time_frame>Baseline, 8 weeks and 12 months</time_frame>
    <description>Testing equivalence between groups</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Chronic Respiratory Disease Questionnaire</measure>
    <time_frame>Baseline, 8 weeks and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Modified Medical Research Council Scale</measure>
    <time_frame>Baseline, 8 weeks and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost-effectiveness</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SF-36 v2</measure>
    <time_frame>Baseline, 8 weeks and 12 months</time_frame>
    <description>Contributes to cost effectiveness analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Program completion rate</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">144</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <arm_group>
    <arm_group_label>Home-based pulmonary rehabilitation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Home visit plus 8 weeks of once-weekly telephone calls</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hospital-based pulmonary rehabilitation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard twice-weekly 8-week outpatient pulmonary rehabilitation program</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Home-based pulmonary rehabilitation</intervention_name>
    <description>One home visit plus weekly telephone calls for 8 weeks</description>
    <arm_group_label>Home-based pulmonary rehabilitation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Hospital-based pulmonary rehabilitation</intervention_name>
    <description>Standard twice-weekly 8-week outpatient pulmonary rehabilitation program</description>
    <arm_group_label>Hospital-based pulmonary rehabilitation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  current or former smokers of at least 10 packet years&#xD;
&#xD;
          -  aged 40 years or over&#xD;
&#xD;
          -  diagnosis of COPD confirmed on spirometry.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  previous diagnosis of asthma&#xD;
&#xD;
          -  have attended a pulmonary rehabilitation program in the last two years&#xD;
&#xD;
          -  exacerbation of COPD within the last four weeks&#xD;
&#xD;
          -  have comorbidities which prevent participation in an exercise training program&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anne E Holland, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>La Trobe University, Alfred Health, Institute for Breathing and Sleep</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christine F McDonald, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Austin Health, Institute for Breathing and Sleep</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ajay Mahal, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Monash University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Austin Health</name>
      <address>
        <city>Heidelberg</city>
        <state>Victoria</state>
        <zip>3084</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alfred Health</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <zip>3004</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>August 11, 2011</study_first_submitted>
  <study_first_submitted_qc>August 24, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 25, 2011</study_first_posted>
  <last_update_submitted>August 12, 2019</last_update_submitted>
  <last_update_submitted_qc>August 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 14, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>La Trobe University</investigator_affiliation>
    <investigator_full_name>Anne Holland</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>COPD</keyword>
  <keyword>exercise</keyword>
  <keyword>rehabilitation</keyword>
  <keyword>dyspnea</keyword>
  <keyword>quality of life</keyword>
  <keyword>economic evaluation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

